a glp 1 How GLP-1 medications are transforming diabetes and weight loss treatment and natural appetite control. GLP-1 Receptor Agonists as Treatments

Early medical review helps ensure that treatment decisions are safe, evidence-based, and appropriately monitored

Gastrointestinal effects dominate the tolerability picture Across the Phase 2 obesity, MASH, and diabetes trials, the most consistent finding is a high rate of gastrointestinal adverse events nausea, vomiting, and diarrhea substantially more frequent than placebo

During the meeting, FDA staff scientists highlighted a general lack of quality data supporting safety and effectiveness

Dietary polyphenols promote growth of the gut BacteriumAkkermansia muciniphilaand attenuate high-fat dietinduced metabolic syndrome